We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Health Research Authority (HRA) has launched a new service offered to pharmaceutical companies and research organisations which will accelerate the ethics review stage of clinical trials approval.
MPs have expressed concern that nearly half of clinical trials in the UK fail to publish their results, “presenting risks to human health and increasing research wastage”...
The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical trial sponsors to adequately report their findings is leading to a ....
New data published in The Multiple Sclerosis Journal has shown more promising results for Merck's MS treatment Mavenclad (cladribine tablets) on two subgroups of patients with highly active relapsing multiple sclerosis.